Gong Cheng

Gong Cheng


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2024 in Advanced Science
Verified
Journal Article
Open access
SBShuai Ben
Shuai Ben
ZDZhutao Ding
Zhutao Ding
JXJunyi Xin
Junyi Xin
FLFeng Li
Feng Li
YCYifei Cheng
Yifei Cheng
MWMeilin Wang
Meilin Wang
Genetic and epigenetic alterations occur in many physiological and pathological processes. The existing knowledge regarding the association of PIWI‐interacting RNAs (piRNAs) and their genetic variants on risk and progression of prostate cancer (PCa) is limited. In this study, three genome‐wide association study datasets are combined, including 85,707 PCa cases and 166,247 controls, to uncover genetic variants in piRNAs. Functional investigations involved manipulating piRNA expression in cellular and mouse models to study its oncogenetic role in PCa. A specific genetic variant, rs17201241 is identified, associated with increased expression of PROPER (piRNA overexpressed in prostate cancer) in tumors and are located within the gene, conferring an increased risk and malignant progression of PCa. Mechanistically, PROPER coupled with YTHDF2 to recognize N6‐methyladenosine (m6A) and facilitated RNA‐binding protein interactions between EIF2S3 at 5′‐untranslated region (UTR) and YTHDF2/YBX3 at 3′‐UTR to promote DUSP1 circularization. This m6A‐dependent mRNA‐looping pattern enhanced DUSP1 degradation and inhibited DUSP1 translation, ultimately reducing DUSP1 expression and promoting PCa metastasis via the p38 mitogen‐activated protein kinase (MAPK) signaling pathway. Inhibition of PROPER expression using antagoPROPER effectively suppressed xenograft growth, suggesting its potential as a therapeutic target. Thus, targeting piRNA PROPER‐mediated genetic and epigenetic fine control is a promising strategy for the concurrent prevention and treatment of PCa.

10 April 2025 in Nature Aging
Verified
Journal Article
Closed access
PDF file
YCYifei Cheng
Yifei Cheng
BLBingxin Liu
Bingxin Liu
JXJunyi Xin
Junyi Xin
XWXiaobin Wu
Xiaobin Wu
WLWenchao Li
Wenchao Li
MWMeilin Wang
Meilin Wang

1 July 2021 in Genomics
Verified
Journal Article
Closed access
YLYuenan Liu
Yuenan Liu
ZHZiwei Huang
Ziwei Huang
GCGong Cheng
Gong Cheng
YSYi Shou
Yi Shou
JXJiaju Xu
Jiaju Xu
XZXiaoping Zhang
Xiaoping Zhang

17 October 2020 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
DCDongliang Cao
Dongliang Cao
YMYixuan Meng
Yixuan Meng
SLShuwei Li
Shuwei Li
JXJunyi Xin
Junyi Xin
SBShuai Ben
Shuai Ben
GCGong Cheng
Gong Cheng
Background: Evidence suggests that serum retinol level is associated with prostate cancer risk, but the association between genetic variants in the retinol metabolism pathway genes and prostate cancer risk remains unclarified.Methods: Single‐nucleotide polymorphisms (SNPs) in 31 genes in the retinol metabolism pathway were genotyped to evaluate the association with prostate cancer risk in 4,662 cases and 3,114 controls from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. The gene expression analysis was evaluated using data from the Gene Expression Omnibus (GEO) datasets and the Cancer Genome Atlas (TCGA) database. Data from the Genotype‐Tissue Expression (GTEx) project dataset were utilized to perform the expression quantitative trait loci (eQTL) analysis.Results: Two SNPs were significantly associated with prostate cancer risk [rs1330286 in ALDH1A1: odds ratio (OR) = 0.88, 95% confidence interval (CI) = 0.83‐0.94, p = 2.45 × 10−4; rs4646653 in ALDH1A3: OR = 1.17, 95% CI =1.07‐1.27, p = 4.33 × 10−4]. Moreover, the mRNA level of ALDH1A3 was significantly higher in prostate cancer tissues than in normal tissues in both TCGA datasets and GEO datasets (p = 1.63 × 10−12 and p = 4.33 × 10−2, respectively). rs1330286 was an eQTL of ALDH1A1 (P = 2.90 × 10−3).Conclusion: Our findings highlight that genetic variants in retinol metabolism pathway genes are associated with prostate cancer risk.

10 May 2011 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
NFNinghan Feng
Ninghan Feng
BXBin Xu
Bin Xu
JTJun Tao
Jun Tao
PLPengchao Li
Pengchao Li
GCGong Cheng
Gong Cheng
LHLixin Hua
Lixin Hua

1 August 2019 in International braz j urol
Verified
Journal Article
Open access
PDF file
FQFeng Qi
Feng Qi
SWShangqian Wang
Shangqian Wang
HXHaoxiang Xu
Haoxiang Xu
YGYiren Gao
Yiren Gao
GCGong Cheng
Gong Cheng
LHLixin Hua
Lixin Hua
Key words: Robotics; Laparoscopy; Prostatic Neoplasms